Pure Global
NCT06362993

Breast Cancer Screening in Ghana

Testing Approaches to Promote Breast Cancer Screening in Rural Ghana
Penn State University·ClinicalTrials.gov·otherNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Breast Cancer Female
Drug/Device/Intervention
Bundling
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
Penn State University
Timeline & enrollment
Phase
N/A
Start date
Apr 01, 2024
End date
Mar 01, 2025
Enrollment
150 participants
Primary outcome

Clinical breast exam (CBE) utilization at the local clinic

Summary

This study is designed to test the feasibility of two intervention on promoting early
 screening for breast cancer in rural Ghana. In one intervention, screening for breast cancer,
 diabetes and hypertension will be offered together. In another intervention, a series of
 sessions with men will be conducted with a goal to change gender attitudes and increase
 support to women. The investigators' long-term goal is to test these interventions in a
 large-scale randomized controlled trial. The specific aims of this feasibility study are to:
 1) refine the study materials, including the curriculum for the sessions with men, by
 consulting with an expert advisory committee and a local committee, and 2) determine the
 feasibility of the two interventions in four clinic zones in Yilo-Krobo district in eastern
 Ghana (1 clinic in control, 1 clinic in the first intervention, and 2 in the second
 intervention). This trial registration is for the second specific aim.

ICD-10 classifications
Malignant neoplasm: Breast, unspecifiedMalignant neoplasm of breastMalignant neoplasm of breastCarcinoma in situ of breast, unspecifiedPersonal history of malignant neoplasm of breast
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06362993
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06362993 through Pure Global AI's free database. This phase not specified trial is sponsored by Penn State University and is currently Not yet recruiting. The study focuses on Breast Cancer Female. Target enrollment is 150 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.